Matthew M Weiss

This inventor holds 58 USPTO granted patents and 41 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Protein Degraders. Top assignees: Amgen Inc., Kymera Therapeutics, Inc., Teijin Pharma Limited. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew M Weiss. Retrieved from https://idiyas.com/inventor/matthew-m-weiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 58 (Patent Applications = 41)

% Patents Active = 98.3

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 8 (Patent Applications = 43)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 469(Granted Patents)

Forward Citations (Not Self Cited) = 262(Dec 10, 2025)

Location History:

Secaucus, NJ (US) (2021 - 2022)
Boston, MA (US) (2008 - 2024)
New York, NY (US) (2024)
Philadelphia, PA (US) (2024)

Company Filing History:

Kymera Therapeutics, Inc.

patents

1 out of 127

Teijin Pharma Limited

patents

4. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

IRAK Degraders

Protein Degraders

Sodium Channel Inhibitors

MDM2 Degraders

CRBN Ligands

Bicyclic Sulfonamide Compounds

Tricyclic CRBN Ligands

Alkynyl Dihydroquinoline Sulfonamide

Pyridine Sulfonamides

Bicyclic Ketone Sulfonamide

Biaryl Acyl-Sulfonamide Compounds

5-Amino-Oxazepine

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753172 - Double degraders and uses thereof (2026-10-06),

2. 12715877 - Protein degraders and uses thereof (2026-08-25),

3. 12624044 - SMARCA degraders and uses thereof (2026-05-12),

4. 12545659 - IRAK degraders and uses thereof (2026-02-10),

5. 12540127 - CRBN ligands and uses thereof (2026-02-03),

6. 12539295 - IRAK degraders and uses thereof (2026-02-03),

7. 12528785 - MDM2 degraders and uses thereof (2026-01-20),

8. 12454520 - Protein degraders and uses thereof (2025-10-28),

9. 12258341 - IRAK degraders and uses thereof (2025-03-25),

10. 12168057 - IRAK degraders and uses thereof (2024-12-17),

11. 12150995 - IRAK degraders and uses thereof (2024-11-26),

12. 12091411 - IRAK degraders and uses thereof (2024-09-17),

13. 12005134 - Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth (2024-06-11),

14. 11932624 - MDM2 degraders and uses thereof (2024-03-19),

15. 11897882 - Tricyclic crbn ligands and uses thereof (2024-02-13),

Title: The Innovative Journey of Matthew M Weiss

Introduction: Matthew M Weiss is a pioneering inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Matthew M Weiss holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Matthew M Weiss has consistently pushed the boundaries of innovation, leading to significant advancements in his respective industries.

Collaborations: Throughout his career, Matthew M Weiss has collaborated with leading companies, research institutions, and universities to bring his inventions to life, further solidifying his reputation as a visionary inventor.

Conclusion: Matthew M Weiss's passion for innovation and his relentless drive to create have cemented his legacy as a trailblazing inventor in the vibrant city of Boston, MA.

Profile summary based on public USPTO records.